Welcome to our dedicated page for Bowhead Specialty Holdings SEC filings (Ticker: BOW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Bowhead Specialty Holdings's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Bowhead Specialty Holdings's regulatory disclosures and financial reporting.
Bowhead Specialty Holdings Inc. director David Clifford Holman received a grant of 3,361 shares of Common Stock in the form of restricted stock units on April 30, 2026. The award was recorded at a price of $0.00 per share as a stock-based compensation grant, not an open-market purchase.
Following this grant, Holman directly owns 5,716 shares of Bowhead Specialty Holdings Inc. common stock. The filing characterizes the transaction as a non-derivative acquisition through a grant or award, and a footnote clarifies that the reported amount reflects restricted stock units.
Lowenstein Price reported acquisition or exercise transactions in this Form 4 filing.
Bowhead Specialty Holdings Inc. director Lowenstein Price received a grant of 3,361 shares of Common Stock in the form of restricted stock units. The award was recorded at a price of $0.00 per share, bringing Price’s directly owned stake to a total of 3,361 shares after the grant.
Schnidman Ava reported acquisition or exercise transactions in this Form 4 filing.
Bowhead Specialty Holdings Inc. director Ava Schnidman reported equity compensation on a Form 4. She received a grant of 3,361 shares of common stock at a price of $0.00 per share, reflecting restricted stock units. After this grant, she directly holds 5,380 common shares and indirectly holds 1,893 shares through the Ava Schnidman Revocable Living Trust.
Bowhead Specialty Holdings Inc. is asking stockholders to vote at its 2026 virtual annual meeting on April 30, 2026. Investors will elect four Class II directors to terms ending in 2029 and ratify PricewaterhouseCoopers LLP as independent auditor for the 2026 fiscal year.
Stockholders of record as of March 3, 2026, when 32,838,035 common shares were outstanding, may vote online in advance or during the virtual meeting. The board is currently 11 members, with a majority deemed independent under NYSE rules, and uses staggered three-year terms.
The proxy describes director compensation, including a non-employee package anchored around $80,000 in cash and $80,000 in RSUs, and notes that the CEO, Stephen Sills, received 2025 total compensation of $4,309,280. It also details major holders, including GPC Fund at 27.3% and American Family Mutual Insurance Company at 15.3%, and outlines reinsurance and distribution arrangements with American Family affiliates.
Bowhead Specialty Holdings CEO Stephen J. Sills reported bona fide gifts of 255,400 shares of common stock on March 12–13. These G-code transactions reflect gift transfers from his direct holdings and several family trusts and GRATs. After these gifts, he holds 832,150 shares directly, along with multiple indirect trust and entity positions disclosed as of those dates.
Bowhead Specialty Holdings Inc. files its annual report describing a fast-growing specialty property and casualty insurer focused on complex commercial risks. Gross written premiums reached $862.8 million for the year ended December 31, 2025, up from $695.7 million in 2024 and $507.7 million in 2023.
The business is concentrated in Casualty lines, which generated $550.7 million of 2025 premiums, alongside Professional Liability, Healthcare Liability and the newer Baleen Specialty unit. Bowhead mainly writes excess and surplus lines through a craft model for large, complex risks and a digital model for smaller accounts.
The company relies on a strategic partnership with American Family Mutual Insurance Company, which issues policies and cedes 100% of business to Bowhead’s insurance subsidiary in exchange for a ceding fee. A conservative balance sheet, extensive reinsurance program, and investment-grade fixed income portfolio support its underwriting-first strategy and expansion across U.S. specialty markets.
Bowhead Specialty Holdings reported strong growth for the quarter and year ended December 31, 2025. Fourth-quarter gross written premiums rose 21.3% to $224.1 million, with net income of $14.8 million, or $0.44 per diluted share, and a combined ratio of 96.9%.
For full-year 2025, gross written premiums increased 24.0% to $862.8 million and net income grew 40.6% to $53.8 million, or $1.59 per diluted share. Adjusted net income was $55.6 million, or $1.65 per diluted share, with a 13.6% adjusted return on equity and a 96.5% combined ratio. Management highlighted rapid expansion of the Baleen digital platform and reiterated expectations for around 20% gross written premium growth in 2026, led by the Casualty division.
Bowhead Specialty Holdings Inc. CFO and Treasurer Brad Mulcahey reported equity compensation and related tax-withholding transactions in the company’s common stock.
On February 19, 2026, he acquired 25,145 shares through a grant of restricted stock units. On February 20, 2026, he disposed of 1,274 shares, surrendered to the issuer to cover required tax withholdings upon RSU vesting at $24.90 per share. Following these transactions, he directly owned 136,327 common shares.
Bowhead Specialty Holdings Inc. Chief Underwriting Officer David John Newman reported two equity-related transactions in common stock. On February 19, 2026, he acquired 23,488 shares at a stated price of $0.00 per share as a grant of restricted stock units. On February 20, 2026, he disposed of 1,443 shares at $24.90 per share, surrendering them back to the company to cover required tax withholdings upon vesting. After these transactions, he directly held just under 300,000 shares.
Bowhead Specialty Holdings Inc. CEO and President Stephen Jay Sills reported equity compensation grants and related tax withholding activity in Common Stock. On February 19, he received two stock awards totaling 90,703 and 88,566 shares, recorded as grant or award acquisitions at no cash cost.
On February 20, 5,419 shares were surrendered to the issuer to cover required tax withholdings due upon vesting of restricted stock units at $24.90 per share, a tax-withholding disposition rather than an open-market sale. He also reports additional indirect holdings through various family trusts and entities.